Raymond James Financial Inc Bio Affinity Technologies, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 500 shares of BIAF stock, worth $1,305. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$1,305% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
20Shares Held
416KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA125KShares$327,4470.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC53.7KShares$140,2450.0% of portfolio
-
Allworth Financial LP53.7KShares$140,2450.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.6KShares$106,0750.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$72,7790.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $7.12M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...